2022 Holiday Insights Calendar
The Patient Perspective: Evaluating Time and Treatment While Living with Metastatic Breast Cancer
The results of this research demonstrate the time-burden on ER+, HER2- mBC patients and their loved ones when going to receive care and the potential difficulty of care when an IM injection is part of their treatment plan.
Ipsos Update – April 2024
Global happiness, gender equality, ESG… Ipsos Update explores the latest research & thinking on key topics from Ipsos teams around the world.
I’ve Got a Feeling
Read our latest article highlighting an Ipsos framework for how businesses can measure, understand and leverage consumer emotions.
Loving or Loathing: Understanding Affluents’ Relationship with Luxury
Despite the connection that many Affluents have with luxury, there are those who see it as overpriced and a symbol of excess. Revisit our recorded webinar to hear how marketers can appeal to both groups.
Gen AI: From Wow to How
Find out how you and your company can go from “Wow” to “How” with generative AI in the new interactive report from our new series, Insights to Activate.
What the Future: Parenting
Watch our on demand webinar to hear exclusive data and analysis on what today’s (and tomorrow’s) parents want, and how business leaders and policymakers can support them.
The Vibrant Fringes: Spotting opportunities beyond the mainstream
Listening to individuals from the fringes can allow marketers to address an underserved market while also uncovering new opportunities and innovations to build brand equity.
How AI, new drugs, and your DNA will help us live better for longer
What wellness — physical, mental, and otherwise — looks like matters for all of us, as individuals and as consumers. Matt Carmichael, editor of What the Future, looks at what the future could hold.
Shifts: Three forces that will shape the future of wellness
Ipsos Strategy3’s Trevor Sudano looks at the forces that could transform health and wealth in America, from rising temperatures to rising medical bills.
What anti-obesity drugs could shift in how we think about weight
We’re still in the early days of the GLP-1 revolution, but it’s already changing how patients and caregivers think about and treat obesity. WeightWatchers’ Dr. Spencer Nadolsky explains what this shift tells us about the future of wellness.